Coverage
-
September 18, 2013
The U.S. Food and Drug Administration and an Ohio drug repackaging company have struck a deal that will prevent the company from resuming its repackaging and redistributing activities until it proves it's completely fixed its long-standing processing problems, the agency said Wednesday.
1 other articles on this case.
View all »